Authors
Latest:
Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconusEhsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.
Latest:
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025The EnVision Summit, co-founded by Bonnie An Henderson, MD, is a unique family-oriented, multispecialty ophthalmology CME conference, along with a newly introduced optometry track. Henderson sits down with Ophthalmology Times to talk about the 2025 conference that will take place February 14 to 17 at the Caribe Hilton San Juan, in Puerto Rico.
Latest:
Tuning out anxiety: the role of music in cataract surgeryFrom easing fears to improving mood, a recent study explores how music transforms the surgical experience for both patients and health care teams.
Latest:
OSRX expands medication sizes and adds direct-to-patient post-op kitsThese offerings are designed to streamline workflows for eye care professionals and enhance patient experience.
Latest:
Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwideAnswers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Managing neovascular retinal disease in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key.
Latest:
Final Pearls on Managing Dry Eye Patients With ComorbiditiesOphthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Latest:
ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTSConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
Focusing on postinjection endophthalmitisSystemic immunosuppression may prevent devastating complication in patients.
Latest:
Seize underutilized opportunity to treat glaucoma during vitrectomyOphthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
Latest:
Benefits of topography-guided treatments for irregular corneasProcedure can improve best-corrected visual acuity, enhancing quality of life for patients.
Latest:
Inherited retinal diseases meet their therapeutic matchThe retina is a key proving ground for long-held theories of genetics.
Latest:
The evolving role of vitreosurgical simulators in surgical trainingNeed to eliminate errors results in optimization of training of novice surgeons.
Latest:
Considerations for the Future of Biosimilars in the Treatment of Retinal DisordersCarl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Latest:
Weighing treatments for chronic postop cystoid macular edemaPrompt and adequate action is a key to facilitating the best recovery in patients.
Latest:
FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasisOcuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.
Latest:
Increasing your practice’s reach, relevance, and revenue with clinical trialsWorking as an investigator can prove to be a positive experience for physicians
Latest:
Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLsKamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.
Latest:
The eyes offer conjunctival clue to COVID-19A patient's vision loss leads to another diagnosis
Latest:
Unlocking health mysteriesResearchers find a strong link between Alzheimer's disease and retinal thinning
Latest:
Setting the stage in LA: Neda Shamie, MD, on the 19th Annual Controversies in Modern Eye CareThe May 4 event, themed around Star Wars, will feature the latest innovations, foster open discussions, and provide a collaborative environment for networking and learning, with sessions covering IOLs, oculoplastics, glaucoma, retina therapy, and refractive surgical options.
Latest:
From waste to wonder: Transformational advances in scleral allograft technologyUnlocking the potential of donor scleral tissue: Innovations and future applications.
Latest:
Patient case 2: DME Patient Treated with Ranibizumab BiosimilarDilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Latest:
EyeCon 2024: Key takeaways for enhanced patient care from Day 1Optometry cochairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, highlight the conference’s focus on collaboration, featuring topics like red flags for patient care, thyroid eye disease, and diabetes management.
Latest:
Driving practice growth: Expand on link between dry eye, aestheticsOne obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
Latest:
Ocular surface health and IOL choicesEnhanced monofocal technology may benefit patients with cataracts and dry eye.
